Tissue-specific IL-10 secretion profile from term human fetal membranes stimulated with pathogenic microorganisms associated with preterm labor in a two-compartment tissue culture system

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 13, 2014, Pages 1320-1327

  Zaga Clavellina, Verónica ^a   Flores Espinosa, Pilar ^a   Pineda Torres, Montzerrat ^a   Sosa González, Irma ^b   Vega Sánchez, Rodrigo ^c   Estrada Gutierrez, Guadalupe ^d   Espejel Núñez, Aurora ^d   Flores Pliego, Arturo ^d   Maida Claros, Rolando ^e   Estrada Juárez, Higinio ^f   Chávez Mendoza, Angel ^g  

^a Cell Biology Branch Instiuto Nacional de Perinatología 'Isidro Espinosa de los Reyes'   (Mexico)

^b Infectology Hospital   (Mexico)

^c Psychiatric Genetics Department   (Mexico)

^d Immunobiochemistry Branch   (Mexico)

^e Neonatology Branch   (Mexico)

^f INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^g INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Chorioamnionitis; Human fetal membranes; IL 10; Intrauterine infection; Preterm labor

Indexed keywords

INTERLEUKIN 10; IL10 PROTEIN, HUMAN;

AMNION; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DECIDUA; FEMALE; FETUS; FETUS MEMBRANE; GARDNERELLA VAGINALIS; HUMAN; HUMAN TISSUE; MICROORGANISM; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TISSUE CULTURE; CHORIOAMNIONITIS; CHORION; IMMUNOLOGY; IN VITRO STUDY; MICROBIOLOGY; PREGNANCY; SECRETION (PROCESS); TISSUE CULTURE TECHNIQUE;

AMNION; CANDIDA ALBICANS; CHORIOAMNIONITIS; CHORION; FEMALE; GARDNERELLA VAGINALIS; HUMANS; IN VITRO TECHNIQUES; INTERLEUKIN-10; OBSTETRIC LABOR, PREMATURE; PREGNANCY; STREPTOCOCCUS AGALACTIAE; TISSUE CULTURE TECHNIQUES;

EID: 84905455019     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.857397     Document Type: Article

References (63)

1. Mitchell MD, Keelan J. Inflammation and normal labor. In: Peebbles DM, Myatt L, eds. Inflammation and pregnancy. London, UK: Informa Healthcare; 2006:79-93.
2. Romero R, Mazor M, Wu YK, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12:262-79.
3. Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management. Clin Perinatol 2001;28:735-51.
4. Mohan AR, Loudon JA, Bennett PR. Molecular and biochemical mechanisms of preterm labour. Semin Fetal Neonatal Med 2004;9: 437-44.
5. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
6. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
7. de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL- 10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
8. Bean AG, Freiberg RA, Andrade S, et al. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun 1993;61:4937-9.
9. Gérard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
10. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-8.
11. Trautman MS, Collmer D, Edwin SS, et al. Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 1997;4:247-53.
12. Dudley DJ, Edwin SS, Dangerfield A, et al. Regulation of decidual cell and chorion cell production of interleukin-10 by purified bacterial products. Am J Reprod Immunol 1997;38:246-51.
13. Paradowska E, Blach-Olszewska Z, Gejdel E. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta. 1997;18:441-6.
14. Denison FC, Kelly RW, Calder AA, et al. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 1998;13:3560-5.
15. Jones CA, Finlay-Jones JJ, Hart PH. Type-1 and type-2 cytokines in human late-gestation decidual tissue. Biol Reprod 1997;57: 303-11.
16. Simpson KL, Keelan JA, Mitchell MD. Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endocrinol Metab 1998;83:4332-7.
17. Zaga-Clavellina V, Garcia-Lopez G, Flores-Herrera H, et al. In vitro secretion profiles of interleukin (IL)-1beta, IL-6, IL-8, IL-10, and TNF alpha after selective infection with Escherichia coli in human fetal membranes. Reprod Biol Endocrinol 2007;5:46.
18. Greig PC, Herbert WN, Robinette BL, et al. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223-7.
19. Thaxton JE, Sharma S. Interleukin-10: a multi-faceted agent of pregnancy. Am J Reprod Immunol 2010;63:482-91.
20. Roth I, Corry DB, Locksley RM, et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996;184:539-48.
21. Hanna N, Hanna I, Hleb M, et al. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000;164:5721-8.
22. Sacks GP, Clover LM, Bainbridge DR, et al. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta 2001;22: 550-9.
23. Fortunato SJ, Menon R, Swan KF, et al. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation. Am J Obstet Gynecol 1996;175:1057-65.
24. Fortunato SJ, Menon R, Lombardi SJ. Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity. Am J Obstet Gynecol 1997;177:803-9.
25. Pomini F, Caruso A, Challis JR. Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J Clin Endocrinol Metab 1999;84:4645-51.
26. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-82.
27. Zaga V, Estrada-Gutierrez G, Beltran-Montoya J, et al. Secretions of interleukin-1beta and tumor necrosis factor alpha by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci. Biol Reprod 2004;71:1296-302.
28. Miller MF, Loch-Caruso R. Comparison of LPS-stimulated release of cytokines in punch versus transwell tissue culture systems of human gestational membranes. Reprod Biol Endocrinol 2010;8: 121.
29. Thiex NW, Chames MC, Loch-Caruso RK. Tissue-specific cytokine release from human extra-placental membranes stimulated by lipopolysaccharide in a two-compartment tissue culture system. Reprod Biol Endocrinol 2009;7:117.
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54.
31. Zaga-Clavellina V, López GG, Estrada-Gutierrez G, et al. Incubation of human chorioamniotic membranes with Candida albicans induces differential synthesis and secretion of interleukin- 1beta, interleukin-6, prostaglandin E, and 92 kDa type IV collagenase. Mycoses 2006;49:6-13.
32. Zaga-Clavellina V, Martha RV, Flores-Espinosa P. In vitro secretion profile of pro-inflammatory cytokines IL-1β, TNF-α, IL-6, and of human beta-defensins (HBD)-1, HBD-2, and HBD-3 from human chorioamniotic membranes after selective stimulation with Gardnerella vaginalis. Am J Reprod Immunol 2012;67:34-43.
33. Bowen JM, Chamley L, Keelan JA, Mitchell MD. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 2002;23: 257-73.
34. Hillier SL, Krohn MA, Cassen E, et al. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis 1995; 20:S276-8.
35. Donders GG, Moerman P, Caudron J, et al. Intra-uterine Candida infection: a report of four infected fetusses from two mothers. Eur J Obstet Gynecol Reprod Biol 1991;38:233-8.
36. Romero R, Reece EA, Duff GW, et al. Prenatal diagnosis of Candida albicans chorioamnionitis. Am J Perinatol 1985;2: 121-2.
37. Bruner JP, Elliott JP, Kilbride HW, et al. Candida chorioamnionitis diagnosed by amniocentesis with subsequent fetal infection. Am J Perinatol 1986;3:213-8.
38. Baley JE. Neonatal candidiasis: the current challenge. Clin Perinatol 1991;18:263-80.
39. Ng PC, Siu YK, Lewindon PJ, et al. Congenital Candida pneumonia in a preterm infant. J Paediatr Child Health 1994;30:552-4.
40. Murciano C, Yáñez A, O'Connor JE, et al. Influence of aging on murine neutrophil and macrophage function against Candida albicans. FEMS Immunol Med Microbiol 2008;53:214-21.
41. Han KH, Park SJ, Choi SJ, et al. Immunological features of macrophages induced by various morphological structures of Candida albicans. J Microbiol Biotechnol 2013;23:1031-40.
42. Ghosh S, Howe N, Volk K, et al. Candida albicans cell wall components and farnesol stimulate the expression of both inflammatory and regulatory cytokines in the murine RAW264.7 macrophage cell line. FEMS Immunol Med Microbiol 2010;60: 63-73.
43. De Bernardis F, Lucciarini R, Boccanera M, et al. Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis. Infect Immun 2006;74: 4282-94.
44. Lilic D, Gravenor I, Robson N, et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun 2003;71:5690-9.
45. Mitchell MD, Simpson KL, Keelan JA. Paradoxical proinflammatory actions of interleukin-10 in human amnion: potential roles in term and preterm labour. J Clin Endocrinol Metab 2004;89: 4149-52.
46. Gibbs RS, Weiner MH, Walmer K, et al. Microbiologic and serologic studies of Gardnerella vaginalis in intra-amniotic infection. Obstet Gynecol 1987;70:187-90.
47. Menard JP, Mazouni C, Salem-Cherif I, et al. High vaginal concentrations of Atopobium vaginae and Gardnerella vaginalis in women undergoing preterm labor. Obstet Gynecol 2010;115: 134-40.
48. Castro-Leyva V, Espejel-Nuñez A, Barroso G, et al. Preserved ex vivo inflammatory status in decidual cells from women with preterm labor and subclinical intrauterine infection. PLoS ONE 2012;7:e-43605.
49. Peltier MR, Berlin Y, Tee SC, et al. Does progesterone inhibit bacteria-stimulated interleukin-8 production by lower genital tract epithelial cells? J Perinat Med 2009;37:328-33.
50. Zariffard MR, Novak RM, Lurain N, et al. Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005;191:1913-21.
51. Menon R, Peltier MR, Eckardt J, et al. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol 2009;201:306.e1-6.
52. Baker CJ. Group B streptococcal infection in newborns: prevention at last? N Engl J Med 1986;314:1702-4.
53. Ruud TE, Gundersen Y, Wang JE, et al. Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro. Surg Infect (Larchmt) 2007;8:495-503.
54. Zaga-Clavellina V, Merchant-Larios H, García-López G, et al. Differential secretion of matrix metalloproteinase-2 and -9 after selective infection with group B streptococci in human fetal membranes. J Soc Gynecol Investig 2006;13:271-9.
55. Cusumano V, Genovese F, Mancuso G, et al. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect Immun 1996;64:2850-2.
56. Andrade EB, Alves J, Madureira P, et al. TLR2-Induced IL-10 production impairs neutrophil recruitment to infected tissues during neonatal bacterial sepsis. J Immunol 2013;191:4759-68.
57. Bebien M, Hensler ME, Davanture S, et al. The pore-forming toxin b hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog 2012;8:e1002812.
58. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006;177:4888-96.
59. Murphy SP, Hanna NN, Fast LD, et al. Evidence for participation of uterine natural killer cells in the mechanisms responsible for spontaneous preterm labor and delivery. Am J Obstet Gynecol 2009;200:308.e1-9.
60. Rivera DL, Olister SM, Liu X, et al. Interleukin-10 attenuates experimental fetal growth restriction and demise. FASEB J 1998; 12:189-97.
61. Terrone DA, Rinehart BK, Granger JP, et al. Interleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001;98:476-80.
62. Wallace KL, Lopez J, Shaffery JP, et al. Interleukin-10/ceftriaxone prevents E. coli-induced delays in sensorimotor task learning and spatial memory in neonatal and adult Sprague-Dawley rats. Brain Res Bull 2010;81:141-8.
63. Duell BL, Carey AJ, Tan CK, et al. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J Immunol 2012; 188:781-92.